Overexpression of dominant-negative Ikaros 6 isoform is associated with resistance to TKIs in patients with Philadelphia chromosome positive acute lymphoblastic leukemia

about

Overexpression of dominant-negative Ikaros 6 isoform is associated with resistance to TKIs in patients with Philadelphia chromosome positive acute lymphoblastic leukemia

Item

http://www.wikidata.org/entity/Q42376333

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Overexpression of dominant-neg ...... e acute lymphoblastic leukemia

@en

Overexpression of dominant-neg ...... e acute lymphoblastic leukemia

@nl

type

Item

label

Overexpression of dominant-neg ...... e acute lymphoblastic leukemia

@en

Overexpression of dominant-neg ...... e acute lymphoblastic leukemia

@nl

prefLabel

Overexpression of dominant-neg ...... e acute lymphoblastic leukemia

@en

Overexpression of dominant-neg ...... e acute lymphoblastic leukemia

@nl

P1476

Overexpression of dominant-neg ...... e acute lymphoblastic leukemia

@en

P2093

Changfeng Shao

http://www.w3.org/2001/XMLSchema#string

Cong Cheng

http://www.w3.org/2001/XMLSchema#string

Haiyan Wang

http://www.w3.org/2001/XMLSchema#string

Hongzai Guan

http://www.w3.org/2001/XMLSchema#string

Jie Yang

http://www.w3.org/2001/XMLSchema#string

Wei Lu

http://www.w3.org/2001/XMLSchema#string

Yirong Kong

http://www.w3.org/2001/XMLSchema#string

P2860

Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.

Ikaros and Aiolos inhibit pre-B-cell proliferation by directly suppressing c-Myc expression

Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia.

Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome

Pre-T cell receptor (TCR) and TCR-controlled checkpoints in T cell differentiation are set by Ikaros.

Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.

Ikaros is a regulator of Il10 expression in CD4+ T cells.

Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance.

P304

3874-3879

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2017.4941

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29042995

http://www.w3.org/2001/XMLSchema#string

P921

overexpression

P932

5639309

http://www.w3.org/2001/XMLSchema#string